Masahiro Uni, MD, PhD1,2, Asher Preska Steinberg, PhD2,3*, Alicia Slavit1,2*, Sophia Rha1,2*, Shuyuan Cheng1,2, Laura K. Schmalbrock, MD1,2*, Jiayu Su4,5,6*, Jing Ma, PhD7*, Andrew McPherson, PhD3*, Charles G. Mullighan, MBBS, MSc, MD7, Torsten Haferlach, MD8, Ilaria Iacobucci, PhD9, Jeffery M Klco, MD, PhD7, Raul Rabadan, PhD4,5,10* and Alex Kentsis, MD, PhD1,2,11
1Molecular Pharmacology Program, Sloan Kettering Institute, New York, NY
2Tow Center for Developmental Oncology, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
3Halvorsen Center for Computational Oncology, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
4Program for Mathematical Genomics, Columbia University, New York, NY
5Department of Systems Biology, Columbia University, New York, NY
6New York Genome Center, New York, NY
7Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
8MLL Munich Leukemia Laboratory, Munich, Germany
9St. Jude Children's Research Hospital, Memphis, TN
10Department of Biomedical Informatics, Columbia University, New York, NY
11Departments of Pediatrics, Pharmacology and Physiology & Biophysics, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, NY